Inventiva will gain a new chairman following the deal as it presses ahead with a Phase III trial for its lead asset.

Wuhan YZY Biopharma Co. Ltd. is out-licensing lead candidate M-701, a CD3/EpCAM bispecific antibody, to Chia Tai Tianqing Pharmaceutical Group Co. Ltd. (CTTQ) for China rights in a deal worth up to ...

Shares of Inventiva S.A (IVA) were rallying more than 50 percent in pre-market on Monday after the company secured 94.1 million euros ...

This reflects the confidence of the participating investors and our partner CTTQ in the value of lanifibranor as a breakthrough therapy for patients suffering from MASH. The total proceeds from the ...

Triveni Bio Inc. has announced a $115 million series B financing to support expansion of its pipeline. Bioatla Inc. and Context Therapeutics Inc. have entered into an agreement under which Context has ...

The shareholders of Karolinska Development AB (publ), reg. no. 556707-5048, (“Karolinska Development” or the “Company”) are invited to the Extraordinary General Meeting (“EGM”), on Wednesday, November ...

标准的芦荟汁，如丝般顺滑就是看着有点翻江倒海 ...

(Reuters) -Rio Tinto has been holding talks to buy lithium miner Arcadium, three sources with direct knowledge of the negotiations said, a deal that would make Rio the third-largest producer of the ...